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Background: The burden of acute respiratory infections (ARI) among Moroccan children remains significant.
However, scarce information is available regarding trends in its epidemiology and etiology, or regarding its
associated prognostic factors.
The purpose of this work was to review available data on the burden of ARI among children under five years of
age in Morocco.
Methods: A systematic review was conducted for the period 1997–2014 using the PRISMA proposed methodology.
Various online databases were screened, in addition to physical libraries of Moroccan medical schools, and official
reports of the Moroccan Ministry of Health. Search queries in English and French languages included: Respiratory
Tract Infections, pneumonia, epidemiology, etiology, microbiology, mortality and Morocco. The documents were
included for analysis when they reported original data on the incidence, distribution, or a clinical description of the
diseases or their etiology or described clinical management or national preventive strategies.
Results: Thirty-two documents were included in the final analysis. 21 of which had been published. In 2012, ARI
caused 13% of paediatric deaths, half of the consultations at health facilities and third of the paediatric admissions.
The microorganisms more frequently identified among hospitalized children were Streptococcus pneumoniae (38%)
and Haemophilus influenza type b (Hib) (15%). The MOH introduced Hib vaccines into the national immunization
program (PNI) in 2007and the 13-valent vaccine against pneumococcus in 2010. The national first line antibiotics
recommended for non-severe ambulatory treatment is Amoxicillin. Studies of antibiotic resistance showed from 1998
to 2008 a 22% increase in the rate of penicillin non-susceptibility among Streptococcus pneumoniae isolates. Viral
respiratory infections and the role attributed to air pollution in the incidence of ARI have been poorly characterized.
Conclusions: Further efforts should be made towards the development of adequate surveillance programs to better
clarify the epidemiology, etiology, antimicrobial susceptibility patterns and the effectiveness of the preventives and
curatives strategies in place against paediatric ARIs in Morocco. Additionally, a holistical approach should be used to
identify the heath determinants of ARIs among children.
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Current estimates confirm that around 15% of global
deaths in children under the age of 5 are caused by
pneumonia [1,2]. This is equivalent to almost one million
annual child deaths, making it the single biggest killer of
children worldwide. However, some 451 000 lives have
been saved in the last decade, thanks to the protection
of children from indoor pollution, the promotion of
breast feeding and hand washing and to the intensified
worldwide efforts to increase access to effective vac-
cination and treatment management. Despite this, the
high toll imposed by pneumonia remains intolerable.
Reducing the burden of pneumonia mortality is essen-
tial to achieve the fourth Millennium Development
Goal (MDG) of reducing child mortality. To assess how
national programs are progressing towards the reduc-
tion of the disease burden, it appears imperative to
establish adequate surveillance systems capable of: 1)
Measuring this burden; 2) Describing its epidemio-
logical trends and 3) assessing in the detail the under-
lying etiologies and pathogens involved [3].
However, most of the developing countries with high
burden of morbidity and mortality associated to ARI still
lack the necessary data on the real burden, epidemiology
and etiology of ARI within their territories [4,5]. Such
knowledge gaps seriously hinder the capacity of those
countries to evaluate the progress on their preventive
strategies in the fight against pneumonia, or the trend
on antimicrobial sensitivity, which should guide their
treatment policies [6,7]. Indeed, in most of these coun-
tries the estimation of the burden of ARI is based on
specific surveys at the national or regional level, or more
isolated results deriving from hospital records [6,7].
In Morocco, a middle-income country in the North of
Africa, pneumonia in children under five years of age, re-
mains a major public health challenge [2,8]. The Moroccan
Ministry of Health, promotes the integration of multiple
strategies to fight against pneumonia [9,10]. Its pneumonia
specific policies encourage exclusive breastfeeding and
hand washing. At the peripheral level, Morocco uses the
integrated management of childhood illnesses approach
for the early recognition of pneumonia and is adequate
management [11]. Beside this, the Moroccan Ministry
of Health (MOH) introduced in 2007 and in 2011 the
Hib and the pneumococcal (13-valent) vaccines, and
further trained its health professionals in the adequate
management of pneumonia cases.
In spite of these strategies, both the MOH and the
United Nations (UN) still report that the burden of ARI
among Moroccan children remains ostensibly important
despite progresses in the implementation of better treat-
ment and preventive strategies [2]. Presumably, the lack
of adequate updated data on the real burden, etiology
and relevance of pneumonia is an important barrieragainst the implementation of better evidence-based
measures designed to lower the toll associated to re-
spiratory infections.
In this respect, determinants of respiratory disease in
Morocco, are can be seen in many other places, remain
multifactorial [12]. Besides the individual determinants
of infection (pathogen based and human host character-
istics, such as age, gender and other risk factors such as
prematurity, nutritional status and breastfeeding), other
determinants such as environmental exposure (atmos-
pheric pollution and other kinds of indoor pollution,
such as smoke, social determinants (including parental
educational and the socio economical level), may all play
an important role in the epidemiology and the burden of
ARIs in Morocco.
In order to evaluate the current knowledge gaps re-
garding paediatric ARIs In Morocco, we reviewed several
databases (online and in medical school libraries) in
search for relevant publications for the past 17 years,
aiming to identify knowledge, gaps, and challenges ahead
in terms of the prevention, diagnosis and treatment
policies for ARI. We deliberately chose this 17 year long
period because it coincides with the start of the ARI
control program in Morocco and the implementation of
the IMCI program in Morocco.
Methods
A systematic review was conducted using the PRISMA
proposed methodology [13]. Pubmed®, Google Scholar®,
Hinari®, Sciences Direct®, EM Premium® online databases
were screened, in addition to physical libraries of three
Moroccan medical schools (Rabat, Casablanca and Fez)
in search of unpublished PHD theses. Finally, official
reports of the Moroccan Ministry of Health (MOH)
were also searched and publications from 1997 to 2014
reviewed in both French and English languages. The
search query terms used included: (“Severe Acute Re-
spiratory Infections/epidemiology” OR “Severe Acute
Respiratory Infections/etiology” OR “Severe Acute Re-
spiratory Infections/microbiology” OR “Severe Acute
Respiratory Infections/mortality” OR “pneumonia”) AND
“Morocco”). The data found were identified and selected
by two readers: a public health professional and a paedia-
trician using the PRISMA flow chart. (Figure 1 summa-
rizes the flow diagram). After the screening, the two
readers merged the documents to study their eligibility
using items from the PRISMA checklist (title, objective,
study population, study setting, information sources,
process of data collection, and outcome measures) [13].
Then, they made consensus decision about the inclusion
of the eligible documents in the final analysis. The studies
inclusion’s criteria were: reporting original data on the
incidence, distribution, or a clinical description of the
diseases or their etiology or describing medical treatment
Figure 1 Flow diagram for the extraction of the records related to ARI in Morocco among children published from 1996 to 2014.
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the documents implied duplication or when, full texts of
abstracts were not found.
Results and discussion
This first screening yielded seventeen original articles
published in peer review journals, 12 in English language
and five in French, one original paper was published in
French language in a Moroccan peer reviewed journal.
Four abstracts were published in French language and
two in English. Finally three additional MOH reports
were found related to the topic. From the school of
medicine libraries’ , eight unpublished doctoral theses
were extracted. After analysis of each of those publica-
tions, two reporting duplicate results were excluded and
one was found to be not eligible, as it did not report any
original result.
These documents describe paediatric ARI-related sur-
veys in Morocco conducted in the last 17 years. The
data could be classified according to the following three
groups: 1) those documents describing severe pneumoniacases admitted to the university hospitals (7 published, 8
unpublished). 2) Those describing samples obtained from
pneumonia patients and analyzed by laboratories of uni-
versity hospitals (10, all published), and finally, 3) National
data provided from the annual statistics report from the
MOH including a survey evaluating the IMCI program
(one study, published) and a study conducted within the
community (three studies, all published).
Description of national health statistics
The World Health Organization (WHO) reports that
ARI remains in Morocco the leading individual cause of
under five mortality, accounting for a total of 13% of all
deaths in this age group in 2012 [2]. Figure 2 illustrates
the proportion of annual deaths among under five accord-
ing to age group (infant and older children) which can be
attributable to ARIs, from the period 2005 to 2012. Data
show an important decrease of ARI-associated deaths
from 2008 to 2011 among older children. No changes can
be observed for infants during the same period. No differ-
ences in the distribution of death gender were evidenced
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Figure 2 Proportion of under five mortality due to ARI by age group from 2005 to 2012. (Data extracted from the National Health Statistics
annual reports and estimated from death certificates).
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year 2012, only half of the children with suspected pneu-
monia were taken to an appropriate health provider, and
only 49% suffering from pneumonia got antibiotics [2].
The summarized data from 2007–2012 obtained from
Morocco’s National annual health statistics (Figure 3),Figure 3 Evolution of the number of outpatient visits (per age group) to p
proportion of those visits being prescribed antibiotics among children und
from the National Health Statistics annual reports.show that the most commonly notified types of ARI
both in urban and rural areas are pneumonia cases,
followed by severe pneumonia cases. The very severe
cases are less prevalent. The most commonly affected
age group included toddlers age 24–59 months. But the
most severe cases occurred in a higher proportionrimary health care centers for acute respiratory infections (ARI) and the
er five years old at the national level from 2007 to 2012. Data extracted
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proportion of ARI cases which subsequently were pre-
scribed antibiotics, with an increasing trend in all age
groups throughout the study period.
Figure 4, shows the distribution of the incidence of ARI
for the different country regions for which data are avail-
able. Almost 54% of all ARIs are reported from rural areas,
whereas the remaining (46.4%) occur in urban setting.
In the places where the IMCI program has been
implemented, there are some data collected from the
MOH since 1997. The indicators collected estimate the
performance of trained nurses in the diagnosis of pneu-
monia (whether these episodes diagnosed were severe or
not), and the proportion of those receiving antibiotics. A
study of the quality of IMCI six months after its imple-
mentation in two Moroccan regions as a pilot project
showed that following the IMCI program allowed a
better quality of care, measured by better indicators of
correct antibiotic prescription, and a better overall clas-
sification of the severity of illness [11].
Clinical trends and characteristics of ARI in Morocco from
1997 to 2014
Different studies were found describing the clinical char-
acteristics of patients (range 7–700) admitted to publicFigure 4 Map of Moroccan regions for which incidence of pediatric ARI ha
National Health Statistics annual report.paediatric hospitals, including clinical patterns of ARI,
duration of hospitalization, treatments received and
outcomes. The reported observational period in each of
these studies ranged from one to ten years. What
emerges from these studies is that: the majorities were
descriptive studies; only one being a comparative study
and using statistical analysis. Study populations were
also quite distinct, including in certain studies hospitalized
pneumonia cases only, whereas in others, outpatients with
ARI. The inclusion criteria were based on the clinical case
definition, or on radiological or microbiological criteria.
Age at recruitment in these different paediatric studies
ranged from a minimum of two months to up to 15 years
of age. Most of these studies, have never been published
and are available as doctoral theses, and only one reports
the bacteriological evidence of the causative organism
of ARI in half of its studied cases (5/10= 50%). Table 1,
summireses the information collected through these
unpublished studies.
The clinical patterns of ARI throughout the past 17
years have varied in the different studies available. For
instance, studies looking at acute lobar pneumonia and
pleural effusion are common from 1998 onwards. How-
ever, a thesis produced at the university hospital of Fez,
reported 53 cases of purulent pleurisy between 2006 and< 5%
5-10%
10-20%
>20%
ve been summarized for the year 2012. Data extracted from the
Table 1 Unpublished sources of information on ARI in children in Morocco: from 1997 to 2014
Year Place Source Study population Available information
1999 Rabat Paediatric
hospital
Thesis, faculty of medicine of
Rabat
Admitted patients with
bronchopneumonia
Retrospective data: clinical, radiological,
microbiological and outcome of patients.
1999 Rabat Paediatric
hospital
Thesis, faculty of medicine of
Rabat
Inpatients and out patients with
broncholalveolitis
Retrospective data: clinical, radiological and
outcome of patients
2000 Rabat Paediatric
hospital
Thesis, faculty of medicine of
Rabat
Inpatients and out patients with
broncholalveolitis
Retrospective data: clinical, radiological and
outcome of patients.
2003 University hospital of
Casablanca
Thesis, faculty of medicine of
Casablanca
Isolates among children admitted for
invasive pneumococcal disease
Case study
2007 Rabat Paediatric
hospital
Thesis, faculty of medicine of
Rabat
Inpatients with first episode of
broncholalveolitis
Retrospective data: clinical, radiological and
outcomes of patients
2008 University hospital of
Casablanca
Thesis, faculty of medicine of
Casablanca
Inpatients with pleural effusion Retrospective data: clinical, radiological,
microbiological and outcome of patients.
2009 University hospital of
Casablanca
Thesis, faculty of medicine of
Casablanca
patients admitted for acute community
pneumoniae
Retrospective data: clinical, radiological,
microbiological And outcome of patients.
2011 University hospital of
Casablanca
Thesis, faculty of medicine of
Casablanca
Patients admitted for bronchoalveolitis Etiologies of bronchoalveolitis.No virological
investigation.
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show that the frequency of viral bronchoalveolitis
accounted for 10% of cases of ARI admitted to university
hospital. Patients with acute lobar pneumonia and bron-
chopneumonia represented at that time 38% and 40% of
the ARI respectively. However, a recent study [15] re-
ported that among 700 patients admitted to a paediatric
ward in Rabat, fulfilling WHO clinical severe pneumonia
case definition, only 28% of them had a clinical diagnosis
of suspected bacterial pneumonia (as given by the clin-
ician in charge) at the time of discharge. The same study
reported that the nasopharyngeal carriage of respiratory
virus was almost 92% and that invasive bacterial disease
was identified only in 2% of patient [15], in spite of
universal blood culture and PCR investigation of invasive
bacterial diseases screening among all study participants
(n=700). Beside this, and from year 2000 onwards,
the information available from University Hospital of
Rabat, has only focused on cases of viral bronchoalveoli-
tis. Conversely, the reports coming from Hospital of
Casablanca, presented nine blood culture confirmed
cases of pneumococcal community-acquired pneumonia
and 145 further pneumonia cases without bacteriological
confirmation during an observation period of two years.
A further case of pneumonia associated to pleural effusion
secondary to Streptococcus Pneumoniae was reported in a
one year-long survey. In 2000, ARIs accounted for 30% of
all emergency consultations and 20% of the total number
of admissions in the paediatric infectious diseases ward.
[16] The most affected groups of age were infants and
children less than 2 years of age, representing up to 75%
of all paediatrics patients admitted for ARI. This distribu-
tion did not seem to change across the 17 years, since a
published study in 2014 conducted in the same wardshowed similar findings, and reported that almost 30% of
children attending the paediatric emergency department
had respiratory symptoms, and that 42% of those would
be eventually admitted [15].
In terms of seasonality, ARI’s admissions for bronchio-
litis episodes usually peaked during the winter season,
whereas pneumonia and bronchitis are distributed
throughout the year [15]. The most consistent clinical
feature of pneumonia described in these studies during
the 17 years long period of assessment included respira-
tory distress, fever and cough. The average length of stay
ranged usually from two to five days and the associated
in-hospital case fatality rates from one to five percent.
Only one study [15], documented the nutritional status
of children admitted for ARI, and showed that 5% of
these cases occurred in severe malnourished children
(according to a weight for-age Z score WAZ < 3- SD).
Description of laboratory data
Morocco lacks a national established system for the
monitoring of antimicrobial resistance of pathogens
causing ARI. However, there is some information pro-
vided by laboratory university hospitals. During the
period 1994 to 1998, most isolated germs included in
order of frequency Staphylococcus aureus, followed by
Streptococcus pneumoniae and Haemophilus influenzae
type b. These pathogens were isolated from blood or
pleural fluid. The potential role played by viruses in the
etiology of pneumonia was not at all explored before
the epidemic episodes of influenza. Few published stud-
ies reported the clinical features of the epidemic epi-
sodes of influenza H1N1 in 2009 [17,18], and showed
that children had the highest proportion of laboratory-
confirmed influenza through the influenza sentinel
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syncitial virus (RSV), parainfluenza, 1,2,3 and Adeno-
virus) explored through this sentinel surveillance are
still not available [19].
More recently in 2014, data from a paediatric univer-
sity hospital reported that the invasive pneumococcal
disease was infrequent, but the nasal and nasopharyngeal
carriage of S. pneumonia was common. [15] In this same
study, a full panel of respiratory viruses was screened
among all study participants (n=700), yielding extremely
high (>90%) nasopharyngeal mono or multiples infec-
tion rates. Most commonly identified viruses included
Rhinovirus followed by respiratory syncytial virus (RSV)
and Adenovirus. Importantly, Human metapneumovirus
was also frequently detected and the only of those viral
pathogens independently and significantly associated with
an adverse outcome [15].
Regarding the monitoring of antimicrobial susceptibil-
ity, some data are available for Streptoccoccus pneumo-
niae. Active laboratory surveillance was held from 1994
onwards in the microbiology laboratory of University
Hospital of Casablanca, including all the strains collected
from the wards (adult and paediatric) of three university
hospitals located in Casablanca [20]. Among 1152 strains
collected over these 14 years of ongoing surveillance,
antibiotic susceptibility for this pathogen decreased signifi-
cantly, and importantly, antibiotic resistance was more
prevalent among isolates from children. From 1994–1997,
12.5% of the strains were found to have reduced suscepti-
bility to penicillin, this figure increasing to 15. 3% from
1998 to 2001 [21], to 18. 9% from 2002 to 2005, and to 23.
5% from 2006–2008 [22,23]. This study included all types
of strains. The same center had contributed in the collec-
tion of data within a regional network (ARMed) [24]
during the period 2003 to 2005. Notably, Morocco’s
Streptococcus pneumoniae isolates had one of the highest
erythromycin resistances within the network. In the city of
Rabat two independent surveys were conducted in two
distinct university hospitals during the periods 1997 to
2001 and 2006 to 2007, also trying to assess the antibiotic
susceptibility patterns of Streptocococcus pneumoniae [25]
and other respiratory pathogens [26]. The first study
showed a low susceptibility to beta-lactams (7,8%), but
one of the resistant isolates had been isolated from the
cerebrospinal fluid of an infant with meningitis secondary
to meningeal breach [25]. The second study showed that
2/6 (33.3%) of the pneumococci were fully susceptible to
amoxicillin, and 80% to erythromycin. 91 strains of H.
influenzae type b were also obtained and investigated [27]
with the vast majority (97, 9%) being susceptible to amo-
xicillin+/clavulanic acid, and the totality (100%) to cepha-
losporins. This study showed the lowest resistance rates to
penicillin from Streptococcus pneumoniae observed in
Northern Africa [24].Samples collected in 2010 within a hospital setting,
from patient’s under 5 years of age admitted for severe
clinical pneumonia [28], showed that S.pneumoniae
isolates had moderately low resistance rates to
commonly available antibiotics (Erythromycin 20%,
cotrimoxazole 24%, penicillin G 10% and amoxicillin
14.6% ) [28].
The surveillance of pneumococcal serotype distri-
bution among admitted patients in Casablanca, before
the introduction of the pneumococcal vaccine, showed
that the most prevalent circulating serotypes were 19F,
14,6,18 and 9 [22]. The same distribution was also con-
firmed among healthy children, in whom the preva-
lence of nasopharyngeal carriage was 45, 8% [29]. The
analysis of the carriers, suggested that carriage was
more likely in children who had exclusively breastfed
for less than two months, had a low socio.economic
background, or lived in crowded houses [29]. The com-
monly identified serotypes included 19 F,6,14,23,18 and
9. In a study conducted in Rabat city [15], coinciding
with the year of pneumococcal vaccine implementation,
the most prevalent serotypes isolated among these
admitted patients were 6A, 19F and 6B. The current
13-valent vaccine, introduced into the national
immunization program in 2011, would cover up to 85%
of isolates.Clinical management of ARI
Outside the public sector, management of ARI in
Morocco is difficult to document, due to the widespread
availability of private practitioners’ in urban areas and
some of rural areas in the country. In these ambulatory
private settings there are no official documents which
reflect the private physician’s practices. IMCI guidelines,
which propose a standardized and documented approach
to diagnosis and management, have not been properly
assessed at national scale in Morocco, and thus, little
information exists on how they are truly applied in the
rural areas. Conversely, in university hospital settings,
specific protocols for the management of ARI based on
consensus exist and are followed.
A recent study conducted in the university hospital of
Rabat [28], reports that before their admission, 30% of
patients with ARI received antibiotics within the two
weeks preceding their hospitalization. These antibiotics
were prescribed in 86.5% of the cases by a physician.
The most common antibiotics used prior to arrival to
hospital, were Amoxicillin/Clavulanic acid, followed by
amoxicillin and Macrolides. The same study docu-
mented that once admitted, these same patients often
received in decreasing order of frequency, cephalospor-
ines, macrolides and gentamicin. Most of these antibi-
otics were given parenterally.
Table 2 Keys knowledge gaps regarding paediatric ARIs
in Morocco
Keys knowledge gaps regarding pediatric ARIs in Morocco
□ lack of consistent and homogeneous case definitions for ARI
within the different sources of data (primary health care,
district and University Hospitals )
□ Absence of a systematic microbiological surveillance for the
etiology of ARI in the hospital setting
□ Generalized absence of data for the etiology of non-severe
ARI within the community
□ Poor assessment of viral etiology of ARI
□ Lack of evidence on the role of air pollution as a contributor
to the incidence and the severity of ARI
□ Lack of investigation on the social determinants of ARI and the
access to care
□ Evidence-based data is produced depending on the focus of
interest of the clinical wards and the research laboratories.
□ There is no evaluation or control of the effectiveness and
adequacy of the antibiotics prescribed for ARI
□ The local risk factors for ARI have been poorly explored.
□ The epidemiological indicators which could permit the study
of the impact of the introduction of conjugate pneumococcal
vaccines are not collected
□ Lack of a strategic long term ARI plan at the research and
policy level.
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Specific data on independent risk factors for ARI are
poorly described, and often never explored in the
unpublished studies. However, infants and males ap-
pear to be consistently more at risk of being admitted
as result of their ARI.
A recent survey [30], reported the risk factors of poor
outcomes among children admitted for clinically severe
pneumonia. The main independent risk factors for
death or the requirement of the admission to the inten-
sive care unit included prematurity, exposure to passive
smoking at home, history of fever, the presence of
cyanosis, pallor, ronchi at chest auscultation, uncon-
sciousness on admission and human metapneumovirus
infection. Other common risk/protective factors de-
scribed in the literature (breastfeeding, age, malnutri-
tion, parental and socio economical and educational
level) were also explored in this study, but were not
found to be associated in multivariate analysis with an
adverse outcome.
One study was conducted within the community
to assess the exposure of children to passive smoking
and showed that around 34% of children participat-
ing were exposed at home [31]. Another study con-
ducted in a hospital setting described slightly higher
exposure rates (up to 40%) among children admitted
with ARI [15].
The role of indoor pollution in relation to ARI was
never explored. However, a single study exploring the air
pollution as a determinant of asthma among schoolchil-
dren in an industrialized city, was found and suggested
that the children living in the most polluted industrial
zone were most affected by respiratory diseases and, in
particular, asthma and that the majority of the affected
children were from underprivileged families and were
malnourished [32].
Little anthropological research has been conducted
in Morocco to assess whether family behaviors could
affect or influence the management of ARI among
children. A single study was done during 1998 in the
region of Marrakech [33]. The study showed that the
parental socio economical and educational level, and
that access to the health system, or to transportation
had an important influence in the parent’s behaviors.
Illiterate parents predominantly preferred to start
treating their sick children at home and herbal rem-
edies were typically used. Additionally, visits to the
traditional healers, which may also use herbs or more
aggressive practices, including burning of the chest
using a piece of burning charcoal through a blanket
were also common. Such parents would only visit the
physician as a last resource, when the previous
methods had shown to fail, possibly coinciding with a
worsening condition of their child. In Morocco, theabundance of a private medical sector has been re-
lated to an abuse or misuse of antibiotics, and to
challenges related with the radiography examination
of the chest among patients with suspected pneumo-
nia, possibly in relation to high costs [33].
Available data reviewed regarding acute respiratory
infections in Morocco in the past 17 years, offer a
blurred picture (Table 2). Indeed, the scarcity of
official published or unpublished data regarding the
number one killer of children in Morocco is disquiet-
ing. Among the few available reports, consisting
mostly of ad hoc descriptive studies from admitted
patients to university hospitals, data are difficult to
compare and to generalize, because the National
Health Statistics do only represent the data collected
from the public sectors. The private sector does not
participate to the national health statistics, which cuts
off the national statistics of important data, relating
to the characteristics of the population attending pri-
vate practices and to their care practices. Moreover,
access to the health care system is mostly depending
on the geographical characteristics of the regions and
the contribution of the private health care sector
in these areas. So, the distribution of the ARI in
Morocco shown in figure 4, and the distribution of
ARI between urban and rural areas, may not reflect
the real burden and distribution of ARI within the
country.
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different case definition, or involved different study pop-
ulations. Data produced by hospitals, and in particular
that of the University Hospital of Casablanca, arise from
local laboratories offering microbiological point moni-
toring data of patients admitted to the clinical services
of their structure. While these local data are not repre-
sentative of the rest of the Moroccan population under 5
years of age, the evident scarcity of available data is the
reason behind its usefulness to guide the countries’ first
line treatment against ARI, or similarly, the desired sero-
type composition of the newly introduced pneumococcal
conjugate vaccine. Better, more geographically represen-
tative, detailed etiological and epidemiological data of
the principal pathogens responsible for paediatric ARI
are urgently needed, so as to base in evidence current
recommendations for its prevention and management.
The mortality rate of ARI reported by the national
health statistics in 2010, among children less than one
year old (2,5%) is similar to the mortality rate reported
globally (2,3%) and in developing countries (2,4%) [6].
The same report estimates that 4% of death occurs
within a hospital setting. However, these statistics, like
in many other countries, should be interpreted with cau-
tion, as the sources from which they are gathered may
vary, and because death certificates are not filled uni-
formly, leading to potential over or underestimating the
IRA as causes of death.
In Morocco, ARI-associated mortality statistics do
not seem to show significant differences between
boys and girls, such as those observed in many Asian
countries [6].
The description of the clinical patterns of ARI
throughout the last of 17 years shows a changing profile
of the reported types of cases. More than representing a
real epidemiological transition, sporadic reports seem to
translate the particular focus or scientific interests of
the team of the ward where the data were extracted.
Needless to say, they do represent an important report-
ing bias.
The laboratory studies are few in numbers, are recent,
and are unrelated, using different methods, different
populations of study and different specimens’ types. As a
result, they are difficult to compare, also, and trends in
antimicrobial resistance are challenging to infer. The
laboratory of Casablanca seems to be the single refer-
ence laboratory where long-term surveillance of ARI has
been implemented, and has been providing aggregate
data since the year 1999. This essentially microbiological
surveillance, relatively basic at the moment, should be
optimized by including data on patient’s characteristics,
their clinical manifestations, the prescribed treatments
and outcomes, so as to better describe the burden of
microorganisms isolated and the population at risk.Furthermore, a careful monitoring should also be con-
ducted in the pilot settings where IMCI is implemented
to follow trends of the antimicrobial sensitivity patterns,
particularly in the light of the suspected overuse of anti-
biotics, as antibiotic prescription seems to be also very
common practice. Such data could provide evidence-
based orientation among the identity of antibiotics rec-
ommended through IMCI, their dose adjustments, or a
possible need for replacement.
Only one recently published study documents the
complete picture of clinical severe pneumonia among
admitted children in a university setting, by collecting
individual data, related to the demographic status,
clinical and biochemical characteristics, microbiological
patterns and prognosis factors and the evolution of
the disease [15]. The limitation of this study is that
its results cannot be extrapolated to the entire coun-
try, because this area is better than average covered
in terms of health infrastructures, and is a predomin-
antly urban.
Regarding the pneumococcal conjugate vaccine, the
lack of consistent and geographically representative data
on the circulating serotypes known to cause paediatric
invasive bacterial disease in Morocco hampers our un-
derstanding of the potential effectiveness of the intro-
duction of such vaccine. It would appear essential to
monitor prospectively what pneumococcal serotypes are
still causing disease among Moroccan children, not only
to understand whether this pathogen remains the major
public health concern, but also demonstrate whether
serotype replacement is really occurring [34].
The risk factors identified among admitted children
with ARI are common to those documented in other
settings [35]. Risk factors identified among children in a
hospital setting were related to the management of the
disease, and also relate to the need of the improvement
of the quality of care of patients admitted for ARI.
Among these risk factors an easily preventable one re-
lates to control tobacco exposure. One study reported
that passive smoking is a real concern as a risk factor for
ARIs in Morocco, having this country still not ratified
the convention on the tobacco control [36]. Therefore,
such data can be used as a strong argument to help the
scientific community lobby in the activation of this
process for the protection of the health of children and
citizens in general.
The few available data sources that we have been able
to identify, may adequately describe local patterns of
ARI, but clearly have important limitations as to their
use to describe the burden of ARI at national level or
their extrapolation to the general population to estimate
the burden of disease or epidemiological trends. More-
over, knowledge gaps found of ARI in Morocco identi-
fied by this review seem to be common to other
Analyzed documents
N=32
Samples 
n=15
Ministry of Health 
reports
n=4
Admitted patients 
n=10
Community 
n=3
Microbiology identification n=6
Antibitiotic susceptibility n=7
Nasopharyngeal carriage: n=1
Other: n =1
Patients characteristics n=10
Outcomes n=6
Clinical management n=10
Patient´s behaviors n=2
Patient´s exposure to risk 
factors n=2
Figure 5 Main information identified in the documents included in the systematic review analysis of ARI among children in Morocco. From 1997
to 2014.
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impact of childhood ARI and/or pneumonia is difficult
to assess and to document.
To our knowledge, this is the first review that has
collected evidence from a variety of sources of data for
ARI in Morocco. This is a critical step which has
allowed identifying and summarizing already existing
relevant data, (Figure 5), but also shows the weaknesses
of the current national surveys designed to estimate the
real burden of ARI caused by Streptococcus pneumoniae
and to monitor the antibiotic resistance among the pre-
scribed antibiotics for ARI.
Morocco should promptly develop a set of common
indicators for tracking progress in its fight against pneu-
monia and use these data to identify groups at greater
risk or missed by Health care Services and develop inte-
grative approaches to reach them.
Conclusions
This review confirms the scarcity and limitations of the
available epidemiological, clinical, and microbiological
data regarding ARIs in Morocco, without which evi-
dence based-management and preventive strategies are
difficult to implement. Efforts should be made towards
the development of research strategies on all the fields
of social health determinants of ARIs, to permit a holis-
tic approach for understanding the determinants of ARI
in Morocco and establishing adequate control measures.
Additionally, it would be desirable that Moroccan re-
searchers attempt to disseminate more widely the data
they generate so that it reaches the wider scientific com-
munity and can be used to provide reliable indicators fornational and international policy makers to guide future
preventives and therapeutic strategies based on solid
evidence.Competing interests
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